Hamiformamide
Hamiformamide is a nitric oxide production inhibitor with an IC50 of 49.1 μM, which is isolated from Hamigera avellanea IFM 52957. Hamiformamide inhibits nitric oxide production in macrophage-like cells. Hamiformamide modulates host immune signals.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 179419-82-0
- Formel: C19H18N2O4
- Molecular Weight:338.36
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A498 | IC50 |
1.72 μM
Compound: 4
|
Cytotoxicity against human A498 cells
Cytotoxicity against human A498 cells
|
[PMID: 21667925] |
| ACHN | IC50 |
1.37 μM
Compound: 4
|
Cytotoxicity against human ACHN cells
Cytotoxicity against human ACHN cells
|
[PMID: 21667925] |
| HOP-92 | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human HOP92 cells
Cytotoxicity against human HOP92 cells
|
[PMID: 21667925] |
| Malme-3M | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human MALME-3M cells
Cytotoxicity against human MALME-3M cells
|
[PMID: 21667925] |
| MOLT-4 | IC50 |
1.81 μM
Compound: 4
|
Cytotoxicity against human MOLT4 cells
Cytotoxicity against human MOLT4 cells
|
[PMID: 21667925] |
| NCI-H460 | IC50 |
1.84 μM
Compound: 4
|
Cytotoxicity against human NCI-H460 cells
Cytotoxicity against human NCI-H460 cells
|
[PMID: 21667925] |
| SF-295 | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human SF295 cells
Cytotoxicity against human SF295 cells
|
[PMID: 21667925] |
| SK-MEL-28 | IC50 |
2.03 μM
Compound: 4
|
Cytotoxicity against human SK-MEL-28 cells
Cytotoxicity against human SK-MEL-28 cells
|
[PMID: 21667925] |
| SK-MEL-5 | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human SK-MEL-5 cells
Cytotoxicity against human SK-MEL-5 cells
|
[PMID: 21667925] |
| SK-OV-3 | IC50 |
2.13 μM
Compound: 4
|
Cytotoxicity against human SKOV3 cells
Cytotoxicity against human SKOV3 cells
|
[PMID: 21667925] |
| U-251 | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human U251 cells
Cytotoxicity against human U251 cells
|
[PMID: 21667925] |
| UACC-62 | IC50 |
2.5 μM
Compound: 4
|
Cytotoxicity against human UACC62 cells
Cytotoxicity against human UACC62 cells
|
[PMID: 21667925] |
In Vitro
Hamiformamide (5-100 μM; 2 h pre-incubation, 24 h incubation with LPS) potently inhibits LPS-induced nitric oxide production in RAW264 macrophage-like cells with an IC50 of 49.1 µM while maintaining high cell viability[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 179419-82-0
-
Molecular Weight 338.36
-
Formel C19H18N2O4
-
SMILES
COC1=CC=C(/C=C(NC=O)/C(NC=O)=C/C2=CC=C(O)C=C2)C=C1
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)